Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches -- Ignore unavailable to you. Want to Upgrade?

To: LindyBill who wrote (831)	8/15/2008 1:16:19 PM
From: John Carragher	Read Replies (1) \| Respond to of 39288

didn't dr davis drop co Q-10 from his recommendations,, questionable contributions.. this study is 1994 i assume more recent ones do not support this study? "The one anti-oxidant that stands out by itself for reducing blood pressure is coenzyme Q10 (CoQ10). Eight studies have now examined coenzyme Q's effects on blood pressure, and the pooled data show an impressive average drop of 16 mg Hg in systolic pressure, 10 mg drop in diastolic pressure with CoQ10 (Rosenfeldt F et al 2003). (Doses studied ranged from 50-200 mg per day.) Recent reports have suggested that lowering blood pressure is not enough to eliminate high blood pressure's contribution to cardiovascular complications like death and heart attack. Reduction of abnormal heart muscle thickening, or "hypertrophy" (measured by ultrasound), may also be a necessary aspect of treatment (Devereux RB et al 2004). This effect is not accomplished by all prescription anti-hypertensive medication. Interesting data from the University of Texas-Austin suggests that abnormal hypertrophy resulting from high blood pressure can be substantially regressed with CoQ10 treatment (Langsjoen PH et al 1993; Langsjoen PH et al 1994)."